427 related articles for article (PubMed ID: 12516549)
1. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
[TBL] [Abstract][Full Text] [Related]
2. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
Vinay DS; Kwon BS
Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy.
Sica G; Chen L
Arch Immunol Ther Exp (Warsz); 1999; 47(5):275-9. PubMed ID: 10604232
[TBL] [Abstract][Full Text] [Related]
5. Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation.
Ebata T; Mogi S; Hata Y; Fujimoto JI; Yagita H; Okumura K; Azuma M
Eur J Immunol; 2001 May; 31(5):1410-6. PubMed ID: 11465097
[TBL] [Abstract][Full Text] [Related]
6. Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses.
Tan JT; Ha J; Cho HR; Tucker-Burden C; Hendrix RC; Mittler RS; Pearson TC; Larsen CP
Transplantation; 2000 Jul; 70(1):175-83. PubMed ID: 10919597
[TBL] [Abstract][Full Text] [Related]
7. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
[TBL] [Abstract][Full Text] [Related]
8. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses.
Halstead ES; Mueller YM; Altman JD; Katsikis PD
Nat Immunol; 2002 Jun; 3(6):536-41. PubMed ID: 12021777
[TBL] [Abstract][Full Text] [Related]
9. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.
Cannons JL; Hoeflich KP; Woodgett JR; Watts TH
J Immunol; 1999 Sep; 163(6):2990-8. PubMed ID: 10477561
[TBL] [Abstract][Full Text] [Related]
10. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.
Kim JA; Averbook BJ; Chambers K; Rothchild K; Kjaergaard J; Papay R; Shu S
Cancer Res; 2001 Mar; 61(5):2031-7. PubMed ID: 11280763
[TBL] [Abstract][Full Text] [Related]
11. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.
Flórido M; Borges M; Yagita H; Appelberg R
J Leukoc Biol; 2004 Nov; 76(5):1039-46. PubMed ID: 15316035
[TBL] [Abstract][Full Text] [Related]
12. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
Ruby CE; Redmond WL; Haley D; Weinberg AD
Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
[TBL] [Abstract][Full Text] [Related]
13. 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells.
Choi BK; Bae JS; Choi EM; Kang WJ; Sakaguchi S; Vinay DS; Kwon BS
J Leukoc Biol; 2004 May; 75(5):785-91. PubMed ID: 14694186
[TBL] [Abstract][Full Text] [Related]
14. Thiol levels in CD134-defined subsets of rat T lymphocytes: possible implications for HgCl2-induced immune dysregulation.
Roos A; Claessen N; Schilder-Tol EJ; Chand MA; Weening JJ; Aten J
Biochem Biophys Res Commun; 1997 Nov; 240(2):452-7. PubMed ID: 9388500
[TBL] [Abstract][Full Text] [Related]
15. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
May KF; Chen L; Zheng P; Liu Y
Cancer Res; 2002 Jun; 62(12):3459-65. PubMed ID: 12067989
[TBL] [Abstract][Full Text] [Related]
16. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28.
Hurtado JC; Kim SH; Pollok KE; Lee ZH; Kwon BS
J Immunol; 1995 Oct; 155(7):3360-7. PubMed ID: 7561030
[TBL] [Abstract][Full Text] [Related]
17. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.
al-Shamkhani A; Birkeland ML; Puklavec M; Brown MH; James W; Barclay AN
Eur J Immunol; 1996 Aug; 26(8):1695-9. PubMed ID: 8765008
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CD86 in BALB/c mice infected with Leishmania major does not prevent the expansion of low avidity T cells.
Moro M; Filippi C; Gallard A; Malherbe L; Foucras G; Akiba H; Yagita H; Guéry JC; Glaichenhaus N
Eur J Immunol; 2002 Dec; 32(12):3566-75. PubMed ID: 12516542
[TBL] [Abstract][Full Text] [Related]
19. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression.
Wehler TC; Karg M; Distler E; Konur A; Nonn M; Meyer RG; Huber C; Hartwig UF; Herr W
J Immunol Methods; 2008 Nov; 339(1):23-37. PubMed ID: 18760281
[TBL] [Abstract][Full Text] [Related]
20. A family of ligands for the TNF receptor superfamily.
Cosman D
Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]